Literature DB >> 23835076

Mechanisms of peptide repertoire selection by HLA-DM.

Wouter Pos1, Dhruv K Sethi, Kai W Wucherpfennig.   

Abstract

Recently, crystal structures of key complexes in antigen presentation have been reported. HLA-DM functions in antigen presentation by catalyzing dissociation of an invariant chain remnant from the peptide binding groove and stabilizing empty MHC class II proteins in a peptide-receptive conformation. The crystal structure of a MHC class II-HLA-DM complex explains how HLA-DM stabilizes an otherwise short-lived transition state and promotes a rapid peptide exchange process that favors the highest-affinity ligands. HLA-DO has sequence similarity with MHC class II molecules yet inhibits antigen presentation. The structure of the HLA-DO-HLA-DM complex shows that it blocks HLA-DM activity as a substrate mimic. Alterations in the efficiency of DM-mediated peptide selection may contribute to autoimmune pathologies, which will be an exciting area for future investigation. Published by Elsevier Ltd.

Entities:  

Keywords:  MHC class II molecules; antigen presentation

Mesh:

Substances:

Year:  2013        PMID: 23835076      PMCID: PMC3796002          DOI: 10.1016/j.it.2013.06.002

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  34 in total

1.  Determination of the HLA-DM interaction site on HLA-DR molecules.

Authors:  R C Doebele; R Busch; H M Scott; A Pashine; E D Mellins
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

2.  Interaction of HLA-DR with an acidic face of HLA-DM disrupts sequence-dependent interactions with peptides.

Authors:  Achal Pashine; Robert Busch; Michael P Belmares; Jason N Munning; Robert C Doebele; Megan Buckingham; Gary P Nolan; Elizabeth D Mellins
Journal:  Immunity       Date:  2003-08       Impact factor: 31.745

Review 3.  Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression.

Authors:  Robert Busch; Cornelia H Rinderknecht; Sujin Roh; Andrew W Lee; James J Harding; Timo Burster; Tara M C Hornell; Elizabeth D Mellins
Journal:  Immunol Rev       Date:  2005-10       Impact factor: 12.988

4.  HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH.

Authors:  H Kropshofer; S O Arndt; G Moldenhauer; G J Hämmerling; A B Vogt
Journal:  Immunity       Date:  1997-03       Impact factor: 31.745

5.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide.

Authors:  L J Stern; J H Brown; T S Jardetzky; J C Gorga; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1994-03-17       Impact factor: 49.962

6.  An essential role for HLA-DM in antigen presentation by class II major histocompatibility molecules.

Authors:  P Morris; J Shaman; M Attaya; M Amaya; S Goodman; C Bergman; J J Monaco; E Mellins
Journal:  Nature       Date:  1994-04-07       Impact factor: 49.962

7.  Rheumatoid arthritis (RA)-associated HLA-DR alleles form less stable complexes with class II-associated invariant chain peptide than non-RA-associated HLA-DR alleles.

Authors:  N S Patil; A Pashine; M P Belmares; W Liu; B Kaneshiro; J Rabinowitz; H McConnell; E D Mellins
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

8.  Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM.

Authors:  D A Weber; B D Evavold; P E Jensen
Journal:  Science       Date:  1996-10-25       Impact factor: 47.728

Review 9.  A novel pathway of presentation by class II-MHC molecules involving peptides or denatured proteins important in autoimmunity.

Authors:  James F Mohan; Emil R Unanue
Journal:  Mol Immunol       Date:  2012-11-27       Impact factor: 4.407

10.  Cutting edge: H-2DM is responsible for the large differences in presentation among peptides selected by I-Ak during antigen processing.

Authors:  Scott B Lovitch; Shirley J Petzold; Emil R Unanue
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

View more
  24 in total

Review 1.  Ancient features of the MHC class II presentation pathway, and a model for the possible origin of MHC molecules.

Authors:  Johannes M Dijkstra; Takuya Yamaguchi
Journal:  Immunogenetics       Date:  2018-10-30       Impact factor: 2.846

2.  HLA-DO Modulates the Diversity of the MHC-II Self-peptidome.

Authors:  Padma P Nanaware; Mollie M Jurewicz; John D Leszyk; Scott A Shaffer; Lawrence J Stern
Journal:  Mol Cell Proteomics       Date:  2018-12-20       Impact factor: 5.911

3.  Evaluating the Role of HLA-DM in MHC Class II-Peptide Association Reactions.

Authors:  Liusong Yin; Zachary J Maben; Aniuska Becerra; Lawrence J Stern
Journal:  J Immunol       Date:  2015-06-10       Impact factor: 5.422

Review 4.  The Biology and Underlying Mechanisms of Cross-Presentation of Exogenous Antigens on MHC-I Molecules.

Authors:  Freidrich M Cruz; Jeff D Colbert; Elena Merino; Barry A Kriegsman; Kenneth L Rock
Journal:  Annu Rev Immunol       Date:  2017-01-11       Impact factor: 28.527

5.  Type 2 cytokines in the thymus activate Sirpα+ dendritic cells to promote clonal deletion.

Authors:  Elise R Breed; Matouš Vobořil; Katherine M Ashby; Ryan J Martinez; Lily Qian; Haiguang Wang; Oscar C Salgado; Christine H O'Connor; Kristin A Hogquist
Journal:  Nat Immunol       Date:  2022-05-30       Impact factor: 31.250

Review 6.  HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation.

Authors:  Elizabeth D Mellins; Lawrence J Stern
Journal:  Curr Opin Immunol       Date:  2013-12-08       Impact factor: 7.486

7.  Human Hepatitis B Viral Infection Outcomes Are Linked to Naturally Occurring Variants of HLA-DOA That Have Altered Function.

Authors:  Austin M Graves; Francesca Virdis; Eliot Morrison; Miguel Álvaro-Benito; Aly A Khan; Christian Freund; Tatyana V Golovkina; Lisa K Denzin
Journal:  J Immunol       Date:  2020-07-20       Impact factor: 5.422

Review 8.  Partnering for the major histocompatibility complex class II and antigenic determinant requires flexibility and chaperons.

Authors:  Scheherazade Sadegh-Nasseri
Journal:  Curr Opin Immunol       Date:  2021-06-17       Impact factor: 7.268

9.  Structural Comparison Between MHC Classes I and II; in Evolution, a Class-II-Like Molecule Probably Came First.

Authors:  Yanan Wu; Nianzhi Zhang; Keiichiro Hashimoto; Chun Xia; Johannes M Dijkstra
Journal:  Front Immunol       Date:  2021-06-14       Impact factor: 7.561

10.  Integrated Analysis of lncRNAs, mRNAs, and TFs to Identify Regulatory Networks Underlying MAP Infection in Cattle.

Authors:  Maryam Heidari; Abbas Pakdel; Mohammad Reza Bakhtiarizadeh; Fariba Dehghanian
Journal:  Front Genet       Date:  2021-07-05       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.